Study of the Safety and Effectiveness of Rilonacept for the Prevention of Gout Flares

Completed · Phase 2 · Has a placebo group

Conditions studied: Gout

In brief

This was a clinical research study to determine the safety and effectiveness of an experimental drug called rilonacept in participants with gout who were beginning another additional treatment. Participants participated in this study for approximately 24 weeks. Rilonacept was being studied for use in preventing gout attacks in participants who had gout.

Key facts

Study ID

NCT00610363

Run by

Regeneron Pharmaceuticals

People needed

83

Starts

2007-11-01

Expected to finish

2008-10-01

Last updated by the study team

2017-05-02

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Male or female greater than 18 years of age;
• Previously met the preliminary criteria of the American Rheumatism Association (ARA) for the classification of the acute arthritis of primary gout;
• At least 2 gout flares in the year prior to the screening visit.

You may not qualify if…

• Acute gout flare within 2 weeks of the screening visit and during screening;
• Persistent chronic or active infections;
• History of an allergic reaction to allopurinol;
• History or presence of cancer within 5 years of the screening visit.

Where it is running

• Study site — San Diego, California, United States
• Study site — Santa Maria, California, United States
• Study site — Whittier, California, United States
• Study site — Colorado Srings, Colorado, United States
• Study site — DeLand, Florida, United States
• Study site — Ocala, Florida, United States
• Study site — Orlando, Florida, United States
• Study site — St. Petersburg, Florida, United States
• Study site — Tampa, Florida, United States
• Study site — Tampa, Florida, United States
• Study site — Dunwoody, Georgia, United States
• Study site — Honolulu, Hawaii, United States
• Study site — Boise, Idaho, United States
• Study site — Indianapolis, Indiana, United States
• Study site — South Bend, Indiana, United States
• Study site — Owensboro, Kentucky, United States
• Study site — Wheaton, Maryland, United States
• Study site — Billings, Montana, United States
• Study site — Omaha, Nebraska, United States
• Study site — Reno, Nevada, United States
• Study site — Albany, New York, United States
• Study site — Plainview, New York, United States
• Study site — Roslyn, New York, United States
• Study site — Monroe, North Carolina, United States
• Study site — Raleigh, North Carolina, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.